SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.